![Simon Douglas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Douglas
Président chez
FUSION ANTIBODIES PLC
Fortune : 112 980 $ au 31/07/2026
Profil
Dr. Simon G.
Douglas is a Chairman at EMQN CIC, a Non-Executive Chairman at C-Major Ltd. and a Non-Executive Chairman at Fusion Antibodies Plc.
Dr. Douglas was previously employed as a Non-Executive Chairman by Abselion Ltd., a Non-Executive Chairman by Cambridge Nutritional Sciences Plc, a Chief Executive Officer & Director by Biofortuna Ltd., an Executive Chairman by Lab901 Ltd., a Managing Director by Invitrogen Holdings Ltd., a Chief Executive Officer by DNA Research Innovations Ltd., a Chief Executive Officer by DRI Ltd. (United Kingdom), a Chief Executive Officer by Tepnel Life Sciences Plc, a Head-Technical & Marketing by ICI Group, a Project Leader by GE Healthcare Ltd. (United Kingdom), and a Manager-Business Development by Zeneca, Inc. He received his graduate degree from The University of Southampton and a doctorate degree from The University of Southampton.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FUSION ANTIBODIES PLC 0,69 % | 17/02/2026 | 861 062 ( 0,69 % ) | 112 980 $ | 31/07/2026 |
Postes actifs de Simon Douglas
| Sociétés | Poste | Début |
|---|---|---|
| FUSION ANTIBODIES PLC | Président | 01/09/2011 |
C-Major Ltd.
 C-Major Ltd. Internet Software/ServicesTechnology Services Develops online platform which produces medical devices to reduce the risk of needle stick injuries | Président | 01/09/2019 |
Anciens postes connus de Simon Douglas
| Sociétés | Poste | Fin |
|---|---|---|
HexagonFab Ltd.
 HexagonFab Ltd. Medical SpecialtiesHealth Technology Develops practical measurement tools that helps scientists | Président | 23/03/2026 |
| CAMBRIDGE NUTRITIONAL SCIENCES PLC | Président | 22/04/2024 |
Biofortuna Ltd.
 Biofortuna Ltd. Miscellaneous Commercial ServicesCommercial Services Provides laboratory and diagnostics development and contract manufacturing solutions | Directeur Général | 01/01/2019 |
Lab901 Ltd.
 Lab901 Ltd. Medical SpecialtiesHealth Technology Develops and manufactures laboratory processing products | Président | 01/01/2011 |
Invitrogen Holdings Ltd.
 Invitrogen Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur Général | 01/01/2006 |
Formation de Simon Douglas
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Hologic Ltd.
 Hologic Ltd. Medical SpecialtiesHealth Technology Researches and develops medical diagnostic products | Health Technology |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNA Research Innovations Ltd.
 DNA Research Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Conducts DNA based research | Commercial Services |
Lab901 Ltd.
Lab901 Ltd. Medical SpecialtiesHealth Technology Develops and manufactures laboratory processing products | Health Technology |
Cambridge Nutritional Sciences Plc
 Cambridge Nutritional Sciences Plc Medical SpecialtiesHealth Technology Engages in selling of medical products, primarily in the immunoassay, in-vitro diagnostics market | Health Technology |
ICI Group
 ICI Group Industrial SpecialtiesProcess Industries Manufactures paints & coatings | Process Industries |
Zeneca, Inc. | |
Fusion Antibodies Plc
 Fusion Antibodies Plc Medical/Nursing ServicesHealth Services Develops antibody-based therapeutic products | Health Services |
Invitrogen Holdings Ltd.
Invitrogen Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Biofortuna Ltd.
Biofortuna Ltd. Miscellaneous Commercial ServicesCommercial Services Provides laboratory and diagnostics development and contract manufacturing solutions | Commercial Services |
C-Major Ltd.
C-Major Ltd. Internet Software/ServicesTechnology Services Develops online platform which produces medical devices to reduce the risk of needle stick injuries | Technology Services |
HexagonFab Ltd.
HexagonFab Ltd. Medical SpecialtiesHealth Technology Develops practical measurement tools that helps scientists | Health Technology |
DRI Ltd. (United Kingdom) |
